FCPM III SERVICES B.V. Long-Term Concentrated

CIK: 0002013410 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $582,318 (100.0% shares, 0.0% debt)

Holdings (7)

DYN DYNE THERAPEUTICS INC 36.7%

Value ($000) $213,870 Shares 5,954,069 Est. Cost $12.58 Unrealized +216.5%

NAMS NEWAMSTERDAM PHARMA COMPANY 33.7%

Value ($000) $196,402 Shares 11,831,461 Est. Cost $9.16 Unrealized +88.9%

ENGN ENGENE HOLDINGS INC 9.8%

Value ($000) $57,274 Shares 8,677,951 Est. Cost $10.40 Unrealized -28.5%

REPL REPLIMUNE GROUP INC 9.2%

Value ($000) $53,336 Shares 4,866,449 Est. Cost $11.59 Unrealized -12.4%

BCYC BICYCLE THERAPEUTICS PLC 9.1%

Value ($000) $52,953 Shares 2,339,961 Est. Cost $20.46 Unrealized —

ENGNW ENGENE HOLDINGS INC 1.0%

Value ($000) $6,044 Shares 2,878,148 Est. Cost $0.63 Unrealized —

— ACHILLES THERAPEUTICS PLC 0.4%

Value ($000) $2,438 Shares 2,390,050 Est. Cost $0.89 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
DYN	DYNE THERAPEUTICS INC	5,954,069	$213,870	36.7%	$12.58	+216.5%	COM	26818M108
NAMS	NEWAMSTERDAM PHARMA COMPANY	11,831,461	$196,402	33.7%	$9.16	+88.9%	ORDINARY SHARES	N62509109
ENGN	ENGENE HOLDINGS INC	8,677,951	$57,274	9.8%	$10.40	-28.5%	COM	29286M105
REPL	REPLIMUNE GROUP INC	4,866,449	$53,336	9.2%	$11.59	-12.4%	COM	76029N106
BCYC	BICYCLE THERAPEUTICS PLC	2,339,961	$52,953	9.1%	$20.46	—	SPONSORED ADS	088786108
ENGNW	ENGENE HOLDINGS INC	2,878,148	$6,044	1.0%	$0.63	—	W EXP 10/31/2028	29286M113
—	ACHILLES THERAPEUTICS PLC	2,390,050	$2,438	0.4%	$0.89	—	SPONSORED ADS	00449L102